Clinical Trial Update: Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body [NA]

View source ↗

Summary

This clinical trial, sponsored by MD Anderson Cancer Center, is evaluating dynamic contrast-enhanced MRI as a diagnostic tool for osteoradionecrosis in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Osteoradionecrosis

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Head and Neck Cancer | NA | Status: RECRUITING